Delivery Order SPE2DB22D3019-SPE2DB25FK4EY
- Not listed
- The Defense Logistics Agency awarded a $101,360 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 175ml bottles of the CLENPIQ bowel preparation solution. To be performed in Conshohocken, Pennsylvania from June 27-28, 2023, this order is in support of the DLA's medical supply chain responsibilities for the Department of Defense. As a top 20 Defense Department contractor, Amerisourcebergen will deliver the requested pharmaceutical products without subcontractors. The award...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,439.16 for the supply of Clindamycin 900 mg/50 mL in dextrose 5% water solution on August 21, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,570.81 to AmerisourceBergen Drug Corp for the delivery of 20 DRAM 1-CLIC amber vials. This firm fixed-price, non-set-aside delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine procurement of pharmaceutical packaging materials to support...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,056.07 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,740.75 to AmerisourceBergen Drug Corp on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order will be performed at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $158,944.60 to AmerisourceBergen Drug Corp on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, represents a competitive award with no set-aside designation. The work will be...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,423.41 to AmerisourceBergen Drug Corp on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX. The IDC, valued at $999.999 billion and extending through December 2026,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at approximately $295,000 to AmerisourceBergen Drug Corp on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $1 billion through December 2026. The work will be performed at AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,192.65 to AmerisourceBergen Drug Corp on July 28, 2025, with a completion date of July 29, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,646.74 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The work will be performed at AmerisourceBergen's corporate office...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK4EYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,457.04 to AmerisourceBergen Drug Corp for CLENPIQ 175 ML Solution on September 9, 2025, with a completion date of September 10, 2025. This non-set-aside, firm fixed price delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at approximately $1 billion and extends through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company maintains an extensive portfolio of competitively awarded federal contracts with DLA covering a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. The parent IDC vehicle enables AmerisourceBergen to supply pharmaceutical products globally to support military healthcare programs, including serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This delivery order for CLENPIQ solution represents one of numerous small-value transactions executed through this comprehensive pharmaceutical supply contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/9/25 |